The understanding of autism spectrum disorder as a range of disorders, rather than a singularity, raises the question of whether conditions of the disorders converge on common molecular pathways.

In this lecture, Daniel Geschwind will discuss his group's use of RNA sequencing, chromatin structure and gene networks to help develop an understanding of potential convergent mechanisms in autism spectrum disorders. He will illustrate how knowledge of chromatin structure informs the understanding of gene regulation during human brain development and disease-associated, non-coding variation.

Geschwind will describe his lab’s work leveraging multiple transcriptomic datasets and gene network analyses to predict how risk genes for autism spectrum disorders affect the development and function of brain circuits. His group now uses this framework to explore convergence and divergence with other neuropsychiatric disorders. 

Dr. Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry at the University of California, Los Angeles. He leads the university’s Institute for Precision Health as senior associate dean and associate vice chancellor of precision health. Geschwind has fostered large-scale collaborative patient resources for genetic research and data sharing in autism research and his laboratory helped pioneer the application of systems biology methods in neurologic and psychiatric diseases. He is an elected member of both the Association of American Physicians and the National Academy of Medicine.